Significant gaps in arthritis subtype awareness among US adults underscore the need for improved health literacy and more ...

Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

When psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes ...

Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...

Racial and ethnic diversity is lacking in PsA clinical trials, with non-White participants remaining severely underrepresented.

Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of ...

PsA can be challenging, but these expert-approved tips for reframing how you think, talk, and feel about your condition can ...